Works by Morelli, Gian Luca

Results: 5
    1

    New Combination Regimens vs. Fludarabine, Cytarabine, and Idarubicin in the Treatment of Intermediate- or Low-Risk Nucleophosmin-1-Mutated Acute Myeloid Leukemia: A Retrospective Analysis from 7 Italian Centers.

    Published in:
    Journal of Clinical Medicine, 2025, v. 14, n. 3, p. 700, doi. 10.3390/jcm14030700
    By:
    • Battaglia, Giulia;
    • Lazzarotto, Davide;
    • Tanasi, Ilaria;
    • Gurrieri, Carmela;
    • Forlani, Laura;
    • Mauro, Endri;
    • Capraro, Francesca;
    • Ciotti, Giulia;
    • De Bellis, Eleonora;
    • Callegari, Chiara;
    • Tosoni, Luca;
    • Fanin, Matteo;
    • Morelli, Gian Luca;
    • Simio, Claudia;
    • Skert, Cristina;
    • Gottardi, Michele;
    • Zaja, Francesco;
    • Toffoletti, Eleonora;
    • Damiani, Daniela;
    • Fanin, Renato
    Publication type:
    Article
    2
    3

    P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE "ITALIAN TRIVENETO REGISTRY".

    Published in:
    2023
    By:
    • Luca Morelli, Gian;
    • Fili, Carla;
    • Mauro, Endri;
    • Maria Scattolin, Anna;
    • Mosna, Federico;
    • Gurrieri, Carmela;
    • Nadali, Gianpaolo;
    • Lico, Albana;
    • Sperotto, Alessandra;
    • DE Bellis, Eleonora;
    • Michieli, Mariagrazia;
    • Aloisi, Teresa;
    • Lazzarotto, Davide;
    • Elena Zannier, Maria;
    • Simeone, Erica;
    • Alzetta, Daniel;
    • Battaglia, Giulia;
    • Callegari, Chiara;
    • Pizzano, Umberto;
    • Mullai, Rikard
    Publication type:
    Abstract
    4
    5